CPA Trade Counsel Charles Benoit and Chief Economist Jeff Ferry told Monday’s Prosperity Summit attendees that most economic models are worse at predicting trade outcomes than the local weatherman is at forecasting precipitation levels 10 days out.
The proposed acquisition of U.S. Steel by Japan’s Nippon Steel has understandably generated controversy and concern. At a gut-level, it feels wrong to many Americans.
The U.S. manufacturing boom, which started slowly since the implementation of tariffs on steel, aluminum, some China imports, and sped along by new laws favoring domestic supply chains, has had a positive impact on lower income counties nationwide.
The decision, which will result in nearly 1,000 employee layoffs in April, is a direct result of the U.S. International Trade Commission’s (ITC) determination that illegally dumped and subsidized imports of tin mill products from China, Canada and Germany do not sufficiently harm the U.S. domestic steel industry.
An alarming new report from Horizon Advisory details China’s distortion of the global solar industry and how that threatens the national and economic security of the United States as it “risks making the United States dependent, and dependent on an adversary, for a strategic, future energy source.”
As imports from China rise, the native auto industry will whither at a time when a new auto industry is being born. Call it an opportunity lost.
The World Trade Organization (WTO) may be on its last legs heading into its 13th Ministerial meeting in Abu Dhabi later this month.
The expert witness testimony made it clear that U.S. labs were treated differently than foreign ones, and despite increases in hiring at the FDA over the years, lawmakers have a lot to be concerned about when it comes to the FDA conducting proper oversight of foreign manufacturing facilities.
Section 201 solar safeguard tariffs were supposed to ruin the solar business and completely stall deployment of solar on rooftops and vacant fields controlled by electric utility companies. But according to a U.S. government report, they did nothing of the sort.
According to expert testimony given by the witnesses, the crisis is being fueled by poor manufacturing practices that have led to recalls by foreign drug manufacturers, and the race to the bottom on generic drug prices that make it impossible for American generic drug makers to compete with subsidized competitors in India and China.
